| Name | Title | Contact Details |
|---|---|---|
Peter Vladimirov |
Chief Technology Officer | Profile |
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Calimmune, Inc., a clinical-stage human immunodeficiency virus (HIV) gene medicines company, develops cell-based therapies for HIV. The company offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. It also focuses on developing products to address the needs of various types of individuals at different states of HIV infection and with different levels of treatment experience..
Fluortek is a Easton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Holy Savior Hospice is a healthcare company that provides compassionate, high quality hospice and palliative care services to patients in Texas.
Prince William Health System is a Manassas, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.